Ipca Laboratories appoints Hitesh Kumar Maheshwari as President R&D (Formulations) with effect from October 16, 2023

Hitesh Maheshwari, aged 49 years has completed his B. Pharm from Devi Ahilya Vishwavidyalaya, Indore and M. Pharm from Panjab University, Chandigarh.

Maheshwari brings with him a professional experience of over 24 years. He started his career with Ranbaxy Laboratories in the year 1999 and thereafter worked with Zydus Cadila Healthcare Ltd., Hikma Pharmaceuticals Ltd., Astron Research Ltd. and Macleods Pharmaceuticals Ltd.

Prior to joining Ipca Laboratories, he was associated with Torrent Pharmaceuticals Ltd. as Executive Director and Head – R&D (Formulations). He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company.